Background: Apoptosis is a natural process by which damaged and potentially tumorigenic cells are removed. Induction of apoptosis is important in chemotherapy aimed at eliminating cancer cells. We address the mechanisms by which this process can be triggered in cells that are recalcitrant to cell death induced by DNA-damaging agents. Materials and Methods: Normal human fibroblasts and lymphoblasts, and fibroblasts with defined genetic changes, were treated with DNA-damaging agents and inhibitors of transcription. Westem blotting was used to study the expression of some of the key factors involved in the response to DNA damage and the induction of
INTRODUCTION
Premalignant and aberrant cells are eliminated by mechanisms involving the tumor suppressor p53 (1) (2) (3) (4) (5) . A variety of cellular stresses, such as damaged DNA, viral infection, hypoxia, and depletion of ribonucleotides pool, can trigger posttranslational stabilization and activation of p53 (6-1 1). Activated p53 suppresses cellular growth through induction of either growth arrest (12, 13) and/or apoptosis (1, 14) .
The mechanisms of p53-mediated growth ar-852 rest are fairly well understood and are essentially mediated by transactivation of the gene for the cyclin-dependent kinase inhibitor (CM) p21WAFI,ciPl (15) . Wild-type p53 is also required for Gasl-and c-Abl-mediated growth suppression (16) (17) (18) . Less well understood are the mechanisms of p53-induced apoptosis, its major tumor-suppressing function (19) (20) (21) (22) (23) . p53 induces apoptosis through both transcription-dependent (24, 25) and -independent mechanisms (26) (27) (28) (29) . A transcription-independent apoptotic pathways could involve interactions between p53 and transcription/repair factor TFIIH (28, 30, 31) . Transcription-dependent pathways include regulation of the genes for Bax, Bcl-2, the death receptor CD95 (Fas/APO-1), and the mdm2 proto-oncogene (32) (33) (34) (35) (36) . Up-regulation of pro-apoptotic Bax and 
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Normal fibroblasts [11] [12] [13] [14] [15] CSA fibroblasts [21] [22] [23] [24] CS1AN CSB fibroblasts [15] [16] [17] [18] GM02995 XPC fibroblasts [7] [8] [9] [10] GM03248 XPD fibroblasts [6] [7] [8] [9] XPG fibroblasts [12] [13] [14] [15] down-regulation of anti-apoptotic Bcl-2 sensitizes certain cell types to apoptotic stimuli (32, 37, 38) . y-irradiation of mice leads to p53-dependent up-regulation of Bax and apoptosis only in T lymphocytes and epithelial cells of the small intestine (39) . In contrast to Bax, Mdm2 inhibits p53-mediated apoptosis through binding to the N-terminal transactivation domain (40, 41) . p53 is involved in apoptosis of cell types other than thymocytes and epithelia. Fibroblasts from p53 knock-out mice are resistant to various DNA-damaging agents compared with wild-type (42) . Rapid stabilization of p53 is associated with the high sensitivity of DNA repair-deficient xeroderma pigmentosum (XP) and Cockayne's syndrome (CS) fibroblasts to certain DNA-damaging agents (43, 44) . In this study, we investigated the factors that increase the sensitivity of fibroblasts to apoptosis. We 10 ,uM mitomycin C and samples were collected at the indicated time points. (A) Extracts of XPG fibroblasts were analyzed for p53 and p21WAFl,Cipl protein levels, apoptosis-connected proteolytic cleavage of a 42-kDa protein, and for the presence of extractable DNA, as described for normal fibroblasts in Figure 1. (B) Kinetics of p53 induction and apoptosis in mitomycin C-treated primary fibroblasts. Cell samples were analyzed as in A, but only the p53 immunoblots are shown. Arrows indicate the time when first signs of apoptosis were detected, as in Figure 1 . M, migration of the 1-kb ladder. lanes in Fig. 2B ). Sensitivity to apoptosis seemed to be correlated with the kinetics of p53 induction rather than absolute levels, possibly because the amount of p53 does not reflect activity or that additional factors are involved (note that equal amounts of total protein were analyzed). These results show that deficiencies in transcription-coupled DNA repair rather than overall genome DNA repair increase the rate of apoptosis in fibroblasts.
Transcription Inhibitors Induce Apoptosis of Normal Fibroblasts DNA damage in transcribed DNA could stimulate apoptosis through inhibition of transcription. In this case, inhibitors of transcription might be efficient inducers of apoptosis in normal fibroblasts. We compared the effects of inhibitors of transcription (actinomycin D, a-amanitin, and DRB) and a DNA-damaging agent (cisplatin) on fibroblasts. A short-term treatment was used to study the reaction and the recovery from the effects of the inhibitors. The cells were treated for 12 (Fig. 3A) . However, even after 84 hr (96 hr of total incubation), the majority of the cells were viable (Fig. 3A, (50) and depletion of ribonucleotide triphosphate pools (11) . We show that p53 levels rise In response to transcription inhibitors and cell death is associated with prolonged induction of p53, as would be expected for p53 monitoring of correct transcription that is required for normal progression through the cell cycle.
Normal B lymphoblasts are more sensitive than primary fibroblasts to the DNA-damaging agents mitomycin C and cisplatin, which trigger rapid accumulation of p53 and apoptosis. Proliferating EBV-transformed B cells are known to be sensitive to DNA-damaging agents but growthstimulated primary B lymphoblasts are apparently resistant to cisplatin treatment (51, 52) . The B lymphoblasts that were used in our experiments were not transformed with EBV but still readily underwent apoptosis after challenge with mitomycin C. Their sensitivity to DNA-damaging drugs could be connected with their inability to induce p21wAFl,cipl expression (see below). Primary fibroblasts with defined genetic alterations in DNA repair pathways helped us to identify factors that participate in induction of apoptosis. The resistance of fibroblasts to apoptosis is not simply related to the extent of DNA damage. XPC fibroblasts, which are deficient in repair of transcriptionally silent DNA but not in transcription-coupled DNA repair, are as resistant to DNA damage induced apoptosis as normal fibroblasts. These results are in apparent contradiction with their poor clonogenic survival after UV treatment (43) . A possible explanation is that unrepaired DNA maintains higher levels of p53 and extended growth arrest, which prevents colony formation but not survival. XPD, XPG, and CS fibroblasts, which are deficient in transcription-coupled DNA repair, underwent rapid apoptosis when treated with mitomycin C or cisplatin. Apoptosis may be triggered by the persistence of damage to essential genes or by the failure to restore RNA synthesis (43, 44 Fig. 3A) or CSA, or CSB fibroblasts treated with actinomycin D (Fig. 4) . Mitomycin C treatment of lymphoblasts induces apoptosis and p53 with no increase in p2lwAF1,c1Pl, whereas treatment of fibroblasts does not induce cell death but upregulates both p53 and 2IWAFI,Cipl There is a graded response to aamanitin in that there is extensive cell death when p53 is induced strongly, but p21WAFI,Cipl and Mdm2 are hardly detectable (CSB , Fig. 4B) ; there is less cell death when there is a more pronounced increase in p21WAAFLCiPl and Mdm2 (normal fibroblasts, Fig. 3A) , which is nonetheless delayed compared with normal fibroblasts treated with cisplatin which survive (Fig. 3A) . Apoptosis has always been associated with an increase in p53. For example, a-amanitin stimulated p53 and apoptosis in CSB, but did not affect p53 levels nor stimulate apoptosis in CSA (Fig. 4) . However, high p53 levels per se were not sufficient to induce apoptosis. The rapidity rather than the level of p53 induction was correlated with the sensitivity of repair-deficient cells to apoptosis induced by mitomycin C (see Fig. 2 ). Equivalent amounts of p53 were induced in cisplatin-and actinomycin D-treated CSA and CSB fibroblasts (Fig. 4) , but only cisplatin induced apoptosis. These results suggest that imbalances in the relative levels of induction of p21WAFI ciPl and Mdm2 could affect p53's ability to induce apoptosis. Experiments are in progress to test this hypothesis, using antisense or HPV E6 to modulate the different effectors. Interestingly, rapid down-regulation of p2 1WAFLCiP1 in Baf-3 cells after interleukin 3 (IL-3) withdrawal is associated with rapid apoptosis (59) . Furthermore, several recent studies have shown that the proapoptotic function of p53 is inhibited by p2 1WAFL,Cipl -mediated growth arrest (25, (60) (61) (62) (63) and Mdm2 overexpression (40, 41 (66, 67) , and CSB and TFIIH interact with p53 (30, 31) ; they could affect recruitment and modification of p53.
Stabilized p53 might not always be competent to induce apoptosis. Treatment of fibroblasts with DRB resulted in a strong increase in p53 protein levels but did not lead to apoptosis. DRB inhibits TFIIH-mediated phosphorylation of the C-terminal repeats of the largest subunit of RNA polymerase II and consequently, elongation of transcription (68) . p53 interacts with TFIIH, and it is conceivable that the TFIIH kinase could directly (through phosphorylation of p53) (69) or indirectly (phosphorylation of an auxiliary factor) affect the proapoptotic function of p53. SAP kinases may also influence p53-mediated apoptosis, since they can phosphorylate the N terminus of p53 (70) and are connected with the induction of apoptosis (71, 72) . Finally, downstream effectors of p53 could modulate its apoptotic functions: p21WAFI Cipl by its ability to inhibit cyclin-dependent kinases that phosphorylate p53 (73, 74) , and Mdm2, by complex formation (40, 41) . Our results, in accordance with these studies, suggest that deregulation of the expression of the p53 target genes p2IWAFl,CiPl and Mdm2, and possibly also phosphorylation of 859 p53, could affect the ability of p53 to induce apoptosis in damaged or stressed cells.
In summary, a stressed transcriptional state in the cell may be a trigger for p53 and apoptosis in a manner similar to that in DNA damage or metabolism. Inhibitors of transcription may be useful in treatments aimed at inducing apoptosis of cells that are resistant to DNA-damaging agents. 
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